Projects funded by the NCN
Genetically corrected autologous myogenic cells, associated with nanocapsules as the next generation formula for treatment of Duchenne disease.
2017/25/B/NZ5/01131
Keywords:
Muscular dystrophy myoblasts induced pluripotent stem cells genetic engineering nanotechnology
Descriptors:
- NZ5_7: Human disease treatment
- NZ3_8: Stem cell biology
- ST5_10: Functional materials/nanomaterials, nanoparticles
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Instytut Genetyki Człowieka Polskiej Akademii Nauk
woj. wielkopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 8
Call: OPUS 13 - announced on 2017-03-15
Amount awarded: 1 938 185 PLN
Project start date (Y-m-d): 2018-02-07
Project end date (Y-m-d): 2023-11-06
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.